Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity
- 10 December 1998
- journal article
- Published by Elsevier in Brain Research
- Vol. 813 (2) , 323-328
- https://doi.org/10.1016/s0006-8993(98)01031-2
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1Journal of Biological Chemistry, 1997
- The analgesic effects of R(+)-WIN 55,212–2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic painPublished by Elsevier ,1997
- Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2Life Sciences, 1995
- The formalin test: scoring properties of the first and second phases of the pain response in ratsPain, 1995
- Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction.Proceedings of the National Academy of Sciences, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Central nervous system plasticity in the tonic pain response to subcutaneous formalin injectionBrain Research, 1990
- Subcutaneous formalin-induced activity of dorsal horn neurones in the rat: differential response to an intrathecal opiate administered pre or post formalinPain, 1987
- The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and catsPain, 1977
- Analgesic activity of ?9-tetrahydrocannabinol in the rat and mousePsychopharmacology, 1972